Primary biliary cirrhosis: safety and benefits of established and emerging therapies.

about

The changing faces of cholangitis Activation of Constitutive Androstane Receptor (CAR) in Mice Results in Maintained Biliary Excretion of Bile Acids Despite a Marked Decrease of Bile Acids in Liver

P2860

Q26747051-535C32A5-687B-4E66-84B7-360FB6548995 Q36935450-4150E91B-C240-4995-8207-4844BD743AFE

P2860

Primary biliary cirrhosis: safety and benefits of established and emerging therapies.

Item

http://www.wikidata.org/entity/Q38554677

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Primary biliary cirrhosis: safety and benefits of established and emerging therapies.

@en

type

Item

label

Primary biliary cirrhosis: safety and benefits of established and emerging therapies.

@en

prefLabel

Primary biliary cirrhosis: safety and benefits of established and emerging therapies.

@en

P1476

Primary biliary cirrhosis: safety and benefits of established and emerging therapies.

@en

P2093

James H Tabibian

http://www.w3.org/2001/XMLSchema#string

Keith D Lindor

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a nuclear receptor for bile acids

Cloning of the human cholesterol 7 alpha-hydroxylase gene (CYP7) and localization to chromosome 8q11-q12

Identification of a nuclear receptor that is activated by farnesol metabolites

Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis.

Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice.

Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography.

A human-like senescence-associated secretory phenotype is conserved in mouse cells dependent on physiological oxygen.

Primary sclerosing cholangitis.

Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.

P304

1435-1444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14740338.2015.1073260

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26212223

http://www.w3.org/2001/XMLSchema#string

Primary biliary cirrhosis: safety and benefits of established and emerging therapies.

about

P2860

P2860

Primary biliary cirrhosis: safety and benefits of established and emerging therapies.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698